Molecular subtyping of serous ovarian tumors reveals multiple connections to intrinsic breast cancer subtypes.
<h4>Objective</h4>Transcriptional profiling of epithelial ovarian cancer has revealed molecular subtypes correlating to biological and clinical features. We aimed to determine gene expression differences between malignant, benign and borderline serous ovarian tumors, and investigate simi...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0107643 |
id |
doaj-85eda4e688ad494cb2cbd74e0846e38d |
---|---|
record_format |
Article |
spelling |
doaj-85eda4e688ad494cb2cbd74e0846e38d2021-03-04T09:01:03ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0199e10764310.1371/journal.pone.0107643Molecular subtyping of serous ovarian tumors reveals multiple connections to intrinsic breast cancer subtypes.Jenny-Maria JönssonIda JohanssonMev Dominguez-ValentinSiker KimbungMats JönssonJesper Hansen BondePäivi KannistoAnna MåsbäckSusanne MalanderMef NilbertIngrid Hedenfalk<h4>Objective</h4>Transcriptional profiling of epithelial ovarian cancer has revealed molecular subtypes correlating to biological and clinical features. We aimed to determine gene expression differences between malignant, benign and borderline serous ovarian tumors, and investigate similarities with the well-established intrinsic molecular subtypes of breast cancer.<h4>Methods</h4>Global gene expression profiling using Illumina's HT12 Bead Arrays was applied to 59 fresh-frozen serous ovarian malignant, benign and borderline tumors. Nearest centroid classification was performed applying previously published gene profiles for the ovarian and breast cancer subtypes. Correlations to gene expression modules representing key biological breast cancer features were also sought. Validation was performed using an independent, publicly available dataset.<h4>Results</h4>5,944 genes were significantly differentially expressed between benign and malignant serous ovarian tumors, with cell cycle processes enriched in the malignant subgroup. Borderline tumors were split between the two clusters. Significant correlations between the malignant serous tumors and the highly aggressive ovarian cancer signatures, and the basal-like breast cancer subtype were found. The benign and borderline serous tumors together were significantly correlated to the normal-like breast cancer subtype and the ovarian cancer signature derived from borderline tumors. The borderline tumors in the study dataset, in addition, also correlated significantly to the luminal A breast cancer subtype. These findings remained when analyzed in an independent dataset, supporting links between the molecular subtypes of ovarian cancer and breast cancer beyond those recently acknowledged.<h4>Conclusions</h4>These data link the transcriptional profiles of serous ovarian cancer to the intrinsic molecular subtypes of breast cancer, in line with the shared clinical and molecular features between high-grade serous ovarian cancer and basal-like breast cancer, and suggest that biomarkers and targeted therapies may overlap between these tumor subsets. The link between benign and borderline ovarian cancer and luminal breast cancer may indicate endocrine responsiveness in a subset of ovarian cancers.https://doi.org/10.1371/journal.pone.0107643 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jenny-Maria Jönsson Ida Johansson Mev Dominguez-Valentin Siker Kimbung Mats Jönsson Jesper Hansen Bonde Päivi Kannisto Anna Måsbäck Susanne Malander Mef Nilbert Ingrid Hedenfalk |
spellingShingle |
Jenny-Maria Jönsson Ida Johansson Mev Dominguez-Valentin Siker Kimbung Mats Jönsson Jesper Hansen Bonde Päivi Kannisto Anna Måsbäck Susanne Malander Mef Nilbert Ingrid Hedenfalk Molecular subtyping of serous ovarian tumors reveals multiple connections to intrinsic breast cancer subtypes. PLoS ONE |
author_facet |
Jenny-Maria Jönsson Ida Johansson Mev Dominguez-Valentin Siker Kimbung Mats Jönsson Jesper Hansen Bonde Päivi Kannisto Anna Måsbäck Susanne Malander Mef Nilbert Ingrid Hedenfalk |
author_sort |
Jenny-Maria Jönsson |
title |
Molecular subtyping of serous ovarian tumors reveals multiple connections to intrinsic breast cancer subtypes. |
title_short |
Molecular subtyping of serous ovarian tumors reveals multiple connections to intrinsic breast cancer subtypes. |
title_full |
Molecular subtyping of serous ovarian tumors reveals multiple connections to intrinsic breast cancer subtypes. |
title_fullStr |
Molecular subtyping of serous ovarian tumors reveals multiple connections to intrinsic breast cancer subtypes. |
title_full_unstemmed |
Molecular subtyping of serous ovarian tumors reveals multiple connections to intrinsic breast cancer subtypes. |
title_sort |
molecular subtyping of serous ovarian tumors reveals multiple connections to intrinsic breast cancer subtypes. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2014-01-01 |
description |
<h4>Objective</h4>Transcriptional profiling of epithelial ovarian cancer has revealed molecular subtypes correlating to biological and clinical features. We aimed to determine gene expression differences between malignant, benign and borderline serous ovarian tumors, and investigate similarities with the well-established intrinsic molecular subtypes of breast cancer.<h4>Methods</h4>Global gene expression profiling using Illumina's HT12 Bead Arrays was applied to 59 fresh-frozen serous ovarian malignant, benign and borderline tumors. Nearest centroid classification was performed applying previously published gene profiles for the ovarian and breast cancer subtypes. Correlations to gene expression modules representing key biological breast cancer features were also sought. Validation was performed using an independent, publicly available dataset.<h4>Results</h4>5,944 genes were significantly differentially expressed between benign and malignant serous ovarian tumors, with cell cycle processes enriched in the malignant subgroup. Borderline tumors were split between the two clusters. Significant correlations between the malignant serous tumors and the highly aggressive ovarian cancer signatures, and the basal-like breast cancer subtype were found. The benign and borderline serous tumors together were significantly correlated to the normal-like breast cancer subtype and the ovarian cancer signature derived from borderline tumors. The borderline tumors in the study dataset, in addition, also correlated significantly to the luminal A breast cancer subtype. These findings remained when analyzed in an independent dataset, supporting links between the molecular subtypes of ovarian cancer and breast cancer beyond those recently acknowledged.<h4>Conclusions</h4>These data link the transcriptional profiles of serous ovarian cancer to the intrinsic molecular subtypes of breast cancer, in line with the shared clinical and molecular features between high-grade serous ovarian cancer and basal-like breast cancer, and suggest that biomarkers and targeted therapies may overlap between these tumor subsets. The link between benign and borderline ovarian cancer and luminal breast cancer may indicate endocrine responsiveness in a subset of ovarian cancers. |
url |
https://doi.org/10.1371/journal.pone.0107643 |
work_keys_str_mv |
AT jennymariajonsson molecularsubtypingofserousovariantumorsrevealsmultipleconnectionstointrinsicbreastcancersubtypes AT idajohansson molecularsubtypingofserousovariantumorsrevealsmultipleconnectionstointrinsicbreastcancersubtypes AT mevdominguezvalentin molecularsubtypingofserousovariantumorsrevealsmultipleconnectionstointrinsicbreastcancersubtypes AT sikerkimbung molecularsubtypingofserousovariantumorsrevealsmultipleconnectionstointrinsicbreastcancersubtypes AT matsjonsson molecularsubtypingofserousovariantumorsrevealsmultipleconnectionstointrinsicbreastcancersubtypes AT jesperhansenbonde molecularsubtypingofserousovariantumorsrevealsmultipleconnectionstointrinsicbreastcancersubtypes AT paivikannisto molecularsubtypingofserousovariantumorsrevealsmultipleconnectionstointrinsicbreastcancersubtypes AT annamasback molecularsubtypingofserousovariantumorsrevealsmultipleconnectionstointrinsicbreastcancersubtypes AT susannemalander molecularsubtypingofserousovariantumorsrevealsmultipleconnectionstointrinsicbreastcancersubtypes AT mefnilbert molecularsubtypingofserousovariantumorsrevealsmultipleconnectionstointrinsicbreastcancersubtypes AT ingridhedenfalk molecularsubtypingofserousovariantumorsrevealsmultipleconnectionstointrinsicbreastcancersubtypes |
_version_ |
1714807562165026816 |